Surprisingly, CpG ODNs, particularly non-CpG ODNs composed of guanines, offered a strong suppression of PD-L1/2, indicating that ODNs have the capacity to modify checkpoint protein expression on tumor cells. The gene discussed is CD274; the disease is neoplasm.